Advances in the prevention, management and treatment of community-acquired pneumonia

Pletz, MW; Welte, T; Ott, SR (2010). Advances in the prevention, management and treatment of community-acquired pneumonia. F1000 medicine reports, 2, p. 53. London: BioMed Central

[img]
Preview
Text
5.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (135kB) | Preview

Despite the availability of powerful antibiotics, community-acquired pneumonia (CAP) remains one of the leading reasons for morbidity and mortality worldwide, and despite the availability of powerful antibiotics, there has been only little improvement in case fatality rates for many years. Consequently, it cannot be expected that novel antibiotics will substantially improve outcomes in CAP. Therefore, this review focuses on novel approaches that may reduce CAP-related mortality: the impact of immunomodulation by macrolides and fluoroquinolones and the prevention of CAP by pneumococcal vaccines.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology

UniBE Contributor:

Ott, Sebastian Robert

ISSN:

1757-5931

Publisher:

BioMed Central

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:12

Last Modified:

24 Jan 2015 13:31

BORIS DOI:

10.7892/boris.2325

URI:

https://boris.unibe.ch/id/eprint/2325 (FactScience: 204730)

Actions (login required)

Edit item Edit item
Provide Feedback